Biologics

Category VIEW ALL

chevron_right

Other Technologies (3)

chevron_right

Research Tools (3)

chevron_right

Materials Tech (1)

chevron_right

Communication Tech (1)

chevron_right

Digital Health (3)

chevron_right

In vitro Diagnostics (3)

chevron_right

Medical Devices (7)

chevron_right

Biologics (3)

Small Molecules (3)

Cell Therapies (3)

Other interventions (3)

chevron_right

Fc-engineered lgG1 & IgG3 variants with improved FcRn binding through REW amino acid substitutions

Technology No. DOFI 16003

HLA-II targeting vaccines

Technology No. DOFI 15340

Tandem antibody technology

Technology No. DOFI 20116